CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC S

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for 12 bottles of CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION, with a total contract value of $24.84. The order, issued on July 20, 2026, and set to be delivered no later than August 4, 2026, specifies FOB destination terms, meaning the contractor bears all costs and risks until the item is received at the delivery point: Fort Bragg, North Carolina. The item is identified by NSN 6505013519272 and must be shipped using the fastest traceable means, with parcel post explicitly prohibited. Payment is governed by DFARS 252.232-7003, requiring invoicing through the Wide Area Workflow system to the Defense Finance and Accounting Service in Columbus, Ohio. The awardee is certified as a Small Disadvantaged Women-Owned Business, triggering compliance obligations under FAR and DFARS small business regulations. Inspection and acceptance are performed by the government at the delivery location. No detailed packaging, preservation, marking, or technical specifications are provided beyond the basic item description and logistical instructions, and no Section I contract clauses or Section H special requirements are included in the documentation. Administration is handled by DLA Troop Support’s Medical Supply Chain, with Lisa Quinn as the contracting officer and Shairy Cartagena as the administrative contact. The contract contains no options, indefinite quantities, or additional line items, and serves as a straightforward fulfillment of a single medical supply requirement under an existing basic contract.